Hanmi Pharm. Co., Ltd. (128940.KS)
Hanmi Pharm.
333,000.00+0.07%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+23.3%
The outlook
Hanmi Pharm. Co., Ltd. currently reads as neutral based on strong buy — 1.5 avg of 12 analysts, below its 50- & 200-day averages, 17% of the way from its 52-week low to high, avg target +92% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 12 analysts
Price trendBelow its 50- & 200-day averages
52-week range17% of the way from its 52-week low to high
Price targetAvg target +92% vs current price
Analyst price target
~12-month · 12 analysts638,333.30average target+91.7% vs now
Now 333,000.00
Low 550,000.00High 740,000.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$4.22T
52-wk high
647,000.00
52-wk low
267,500.00
50-day avg
417,130.00
200-day avg
462,140.00
Trailing P/E
—